Basel Medical (BMGL) Cash & Equivalents (2024 - 2025)
Basel Medical (BMGL) posted Cash & Equivalents of $3.0 million for Q4 2025, up 30.17% sequentially from $2.3 million in Q2 2025, and up 56.04% YoY from $2.0 million in Q4 2024.
Basel Medical (BMGL) Cash & Equivalents (2024 - 2025) Analysis & Trends
Basel Medical (BMGL) has 2 years of Cash & Equivalents data on file, last reported at $3.0 million in Q4 2025.
- Quarterly Cash & Equivalents rose 56.04% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 56.04% YoY) and the FY2025 annual result came in at $2.3 million, up 49.8% from the prior year.
- Cash & Equivalents grew to $3.0 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
- The five-year high for Cash & Equivalents was $3.0 million in Q4 2025, with the low at $1.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 940.00 Mn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 16.86 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 2.97 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 644.24 Mn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 110.50 Mn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 539.50 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 119.03 Mn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 247.98 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | 160.28 Mn |
| 10 | Basel Medical | 133.19 Mn | 130.39 Mn | - | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.34 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Dec 31, 2024 | 7.45 Mn |
| Jun 30, 2024 | 1.44 Mn |